Brett Knoblauch
Stock Analyst at Cantor Fitzgerald
(0)
# 3232
Out of 5,267 analysts
211
Total ratings
35.00%
Success rate
3.09%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Core Scientific | Maintains: Overweight | 24 21 | 11.17 | 88% | 5 | Feb 27, 2025 | |
Riot Platforms | Maintains: Overweight | 23 21 | 9.27 | 126.54% | 7 | Feb 25, 2025 | |
Klaviyo | Maintains: Overweight | 47 54 | 39.2 | 37.76% | 5 | Feb 20, 2025 | |
Coincheck Group | Initiates Coverage On: Overweight | 10 | 6.8 | 47.06% | 1 | Feb 19, 2025 | |
IREN | Reiterates: Overweight | 23 23 | 8.21 | 180.15% | 8 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 22 | 17.04 | 29.11% | 6 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 613 619 | 255.49 | 142.28% | 2 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 64 72 | 64.25 | 12.06% | 8 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 10 | 4.07 | 145.7% | 6 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 15 14 | 7.98 | 75.44% | 1 | Jan 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 35 35 | 14.76 | 137.13% | 3 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 11 11 | 4.18 | 163.16% | 6 | Jan 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 9 9 | 8.45 | 6.51% | 10 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 9 9 | 2.06 | 336.89% | 2 | Nov 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 6 1 | 1.5 | -33.33% | 7 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 11 | 9.63 | 14.23% | 8 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 21 | 13.95 | 50.54% | 1 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 23 23 | 7.99 | 187.86% | 5 | Oct 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 13 | 12.32 | 5.52% | 3 | Oct 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.17 | 327.35% | 2 | Oct 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 13 | 14.94 | -12.99% | 7 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 5 7 | 10.84 | -35.42% | 11 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | 1.24 | 61.29% | 8 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 9.48 | 5.49% | 2 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 46 46 | 26.45 | 73.91% | 9 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 21 22 | 7.96 | 176.38% | 10 | Jul 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 23 | n/a | n/a | 6 | Jun 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 2 1 | n/a | n/a | 6 | May 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 3 3 | 3.06 | -5.23% | 2 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 8 8 | 3.54 | 125.99% | 11 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 18 | 4.03 | 346.65% | 6 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 8 | 8.69 | -7.94% | 2 | Feb 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 5 | 4.12 | 21.36% | 1 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 1 | 3.51 | -74.36% | 1 | Nov 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 159 45 | n/a | n/a | 9 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 18 | 1.99 | 804.52% | 2 | Sep 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 9 | n/a | n/a | 4 | Sep 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 48 | 30.33 | 58.26% | 1 | Jul 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 40 | n/a | n/a | 2 | May 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 3 | n/a | n/a | 2 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 9 | n/a | n/a | 3 | Oct 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 5 | 0.25 | 1900% | 2 | Jul 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 33 34 | n/a | n/a | 3 | Jul 27, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 212 | 15.98 | 1226.66% | 1 | Jan 27, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 57 | 32.47 | 75.55% | 1 | Jul 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | n/a | n/a | 1 | Jul 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 46 51 | 64.39 | -20.8% | 2 | Feb 11, 2020 |